Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-22-000062
Filing Date
2022-10-07
Accepted
2022-10-07 16:04:13
Documents
62
Period of Report
2022-08-28

Document Format Files

Seq Description Document Type Size
1 10-Q lndc-20220828.htm   iXBRL 10-Q 1180268
2 EX-31.1 lndc-20220828xexx311.htm EX-31.1 10243
3 EX-31.2 lndc-20220828xexx312.htm EX-31.2 10683
4 EX-32.1 lndc-20220828xexx321.htm EX-32.1 5814
5 EX-32.2 lndc-20220828xexx322.htm EX-32.2 5922
  Complete submission text file 0001005286-22-000062.txt   6065384

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20220828.xsd EX-101.SCH 36350
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lndc-20220828_cal.xml EX-101.CAL 70970
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lndc-20220828_def.xml EX-101.DEF 186982
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20220828_lab.xml EX-101.LAB 533788
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20220828_pre.xml EX-101.PRE 335661
56 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20220828_htm.xml XML 995767
Mailing Address 2811 AIRPARK DRIVE SANTA MARIA CA 93455
Business Address 2811 AIRPARK DRIVE SANTA MARIA CA 93455 6503061650
LANDEC CORP \CA\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: CA | Fiscal Year End: 0530
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 221300790
SIC: 2834 Pharmaceutical Preparations